SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race

Ambarish Pandey; Harriette G.C. Van Spall

doi:10.7326/J23-0071

SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race

Ambarish Pandey, Harriette G.C. Van Spall

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

SOURCE CITATION: Gupta K, Spertus JA, Birmingham M, et al. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials. Circulation. 2023;148:220-228. 37191040.

Original language	English (US)
Pages (from-to)	JC100
Journal	Annals of internal medicine
Volume	176
Issue number	9
DOIs	https://doi.org/10.7326/J23-0071
State	Published - Sep 1 2023

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.7326/J23-0071

Cite this

@article{97889c048ed84049b5c258ee6e6a60df,

title = "SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race",

abstract = "SOURCE CITATION: Gupta K, Spertus JA, Birmingham M, et al. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials. Circulation. 2023;148:220-228. 37191040.",

author = "Ambarish Pandey and {Van Spall}, {Harriette G.C.}",

note = "Funding Information: Janssen Scientific Affairs, LLC.",

year = "2023",

month = sep,

day = "1",

doi = "10.7326/J23-0071",

language = "English (US)",

volume = "176",

pages = "JC100",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "9",

}

TY - JOUR

T1 - SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race

AU - Pandey, Ambarish

AU - Van Spall, Harriette G.C.

N1 - Funding Information: Janssen Scientific Affairs, LLC.

PY - 2023/9/1

Y1 - 2023/9/1

N2 - SOURCE CITATION: Gupta K, Spertus JA, Birmingham M, et al. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials. Circulation. 2023;148:220-228. 37191040.

AB - SOURCE CITATION: Gupta K, Spertus JA, Birmingham M, et al. Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials. Circulation. 2023;148:220-228. 37191040.

UR - http://www.scopus.com/inward/record.url?scp=85171807270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171807270&partnerID=8YFLogxK

U2 - 10.7326/J23-0071

DO - 10.7326/J23-0071

M3 - Comment/debate

C2 - 37665988

AN - SCOPUS:85171807270

SN - 0003-4819

VL - 176

SP - JC100

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 9

ER -

SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this